- Market Realist•2 hours ago
Pharmaceuticals segment Johnson & Johnson’s (JNJ) Pharmaceuticals segment comprises the immunology, infectious disease, neuroscience, oncology, and cardiovascular and metabolics franchises. Immunology ...
- Market Realist•3 hours ago
Performance by business segment Johnson & Johnson’s (JNJ) constant-currency revenue rose ~4.3% between 3Q15 and 3Q16. The company’s 3Q16 revenue of $17.8 billion surpassed analysts’ estimate of $17.7 billion. ...
- Zacks•5 hours ago
Earnings season kicked off on a positive note for the pharma sector with J&J (JNJ) posting strong results.
Johnson & Johnson (JNJ)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||113.49 x 300|
|Ask||113.50 x 400|
|Day's Range||112.99 - 114.24|
|52wk Range||94.28 - 126.07|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||21.14|
|Avg Vol (3m)||6,083,352|
|Dividend & Yield||3.20 (2.70%)|